A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Launched by N-POWER MEDICINE · Mar 10, 2025

Keywords

ClinConnect Summary

This clinical trial is called a "prospective registry," which means it aims to collect important information about cancer patients who are receiving treatment at specific oncology centers. The goal is to gather data on patients' backgrounds, the treatments they receive, and how well those treatments work. Additionally, patients will be asked to fill out surveys about their experiences. This information will help improve research and development in cancer care and make it easier for more patients to participate in clinical trials in the future.

To be eligible for this study, you must be at least 18 years old and receiving care at one of the participating oncology centers. You also need to be willing to provide your consent to participate. The study is currently recruiting participants, and there are no restrictions based on gender, as it is open to everyone. If you decide to join, you can expect to share your treatment details and complete surveys, which will ultimately contribute to better understanding and improving cancer care for everyone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent
• Exclusion Criteria:
• • Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative